Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in

V Salomaa1, V Stinson, J D Kark

  • 1Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki, Finland.

Circulation
|January 15, 1995
PubMed

Insights

This study suggests that thrombosis and impaired fibrinolysis, indicated by higher levels of PAI-1, TPA, and D-dimer, are linked to early atherosclerosis development.

Area of Science:

  • Cardiovascular Research
  • Hematology
  • Vascular Biology

Background:

  • Atherosclerosis progression is linked to plaque rupture and thrombosis.
  • The role of thrombosis and fibrinolysis in early atherosclerosis remains unclear.
  • Defective fibrinolysis may contribute to atherosclerotic lesion development.

Purpose of the Study:

  • To investigate the association between thrombosis/fibrinolysis markers and early atherosclerosis.
  • To determine if PAI-1, TPA, and D-dimer levels correlate with carotid intima-media thickness.

Main Methods:

  • Cross-sectional case-control study of 457 pairs from the ARIC cohort.
  • Cases had carotid intima-media thickness >90th percentile; controls had <75th percentile.
  • Measured plasminogen activator inhibitor antigen (PAI-1), tissue-type plasminogen activator antigen (TPA), and D-dimer.

Main Results:

  • PAI-1, TPA, and D-dimer levels were significantly higher in cases than controls.
  • Increased odds ratios for carotid atherosclerosis were observed with higher quartiles of PAI-1, TPA, and D-dimer.
  • A significant linear trend supported the association between these markers and atherosclerosis.

Conclusions:

  • Findings support the hypothesis that thrombosis and fibrinolysis are involved in early atherosclerosis.
  • Thrombotic and fibrinolytic factors may play a role in the initial stages of atherosclerotic lesion development.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...